lurtotecan liposome

DRUG3 trials

Sponsors

NCIC Clinical Trials Group

Conditions

Fallopian Tube CancerHead and Neck CancerLung CancerOvarian CancerPeritoneal Cavity CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

CompletedNCT00006036

NCIC Clinical Trials GroupHead and Neck Cancer, Lung Cancer, Ovarian Cancer +1

Start: 2000-03-22End: 2009-12-21Updated: 2020-04-06

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

CompletedNCT00003891

NCIC Clinical Trials GroupUnspecified Adult Solid Tumor, Protocol Specific

Start: 1999-02-25End: 2008-09-22Updated: 2020-04-09

Phase 2

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

CompletedNCT00010179

NCIC Clinical Trials GroupFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Start: 2000-10-31End: 2008-09-22Updated: 2020-04-06